Science to practice: Can MR imaging provide a noninvasive "biopsy" of the heart to measure iron levels?

Radiology

Volumn 234, Issue 3, 2005, Pages 647-648

  Bluemke, David A ^a   Liddell, Robert P ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD TRANSFUSION; CLINICAL PRACTICE; DIAGNOSTIC IMAGING; DIFFUSION WEIGHTED IMAGING; HEART MUSCLE BIOPSY; IRON ABSORPTION; IRON BLOOD LEVEL; IRON OVERLOAD; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SHORT SURVEY; VALIDATION PROCESS; BIOPSY; HEART MUSCLE; HUMAN; METABOLISM; METHODOLOGY; REVIEW;

IRON;

BIOPSY; HUMANS; IRON; IRON OVERLOAD; MAGNETIC RESONANCE IMAGING; MYOCARDIUM;

EID: 15944381960     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2343041670     Document Type: Short Survey

References (5)

1. Hoffbrand AV. Diagnosing myocardial iron overload. Eur Heart J 2001; 22:2140-2141.
2. Wang ZJ, Lian L, Chen Q, Zhao H, Asakura T, Cohen AR. 1/T2 and magnetic susceptibility measurements in a gerbil cardiac iron overload model. Radiology 2005; 234:749-755.
3. Wang ZJ, Li S, Haselgrove JC. Magnetic resonance imaging measurement of volume magnetic susceptibility using a boundary condition. J Magn Reson 1999; 140:477-481.
4. Anderson LJ, Holden S, Davis B, et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 2001; 22:2171-2179.
5. Jensen PD, Jensen FT, Christensen T, Eiskjaer H, Baandrup U, Nielsen JL. Evaluation of myocardial iron by magnetic resonance imaging during iron chelation therapy with deferrioxamine: indication of close relation between myocardial iron content and chelatable iron pool. Blood 2003; 101:4632-4639.